October 7, 2010 - Taking medication at night instead of in the morning significantly increases efficacy in ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
October 4, 2010 โ The U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee ...
September 24, 2010 - Trial data have established the safety of a reversible PAR-1 thrombin receptor antagonist in ...
A new class of antiplatelet therapy drug pending U.S. Food and Drug Administration (FDA) clearance may offer ...
September 15, 2010 โ A study evaluating the level of platelet aggregation achieved after switching from ...
September 15, 2010 โ The U.S. Food and Drug Administration (FDA) has extended the time to complete its review of ...
September 8, 2010 โ The increased effectiveness of ticagrelor (Brilinta) in overcoming high platelet reactivity as ...
September 7, 2010 - With increasing rates of patients with atrial fibrillation program suffering from severe ...
September 2, 2010 - Women and men with a 10-year cardiovascular disease risk of 5 percent or more and normal ...
August 30, 2010 โ According to the results of a late-breaking analysis involving more than 200 000 patients in ...
August 18, 2010 - The U.S. Food and Drug Administration (FDA) today proposed to withdraw approval of the drug ...
August 2, 2010 โ Research by an international team of scientists, including a University of California (UC) ...
July 29, 2010 โ A new, highly anticipated antiplatelet drug was recommended yesterday for final approval by the U ...
July 26, 2010 โ The U.S. Food and Drug Administration (FDA) approved the first generic version of Lovenox ...
July 26, 2010 โ A new three-in-one combination drug has been approved by the U.S. Food and Drug Administration ...